期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

精神分裂症认知功能损害的神经生化机制与治疗 被引量：3

Neurochemical mechanisms and treatments of the cognitive impairments in schizophrenia
原文传递
导出
摘要 克雷丕林于1896年提出“早发性痴呆”的定义时就将认知功能损害描述为精神分裂症的特征性症状。近年来有学者提出精神分裂症由阳性症状、阴性症状、情感症状、解体症状和认知损害5种症状组成，严重影响了患者的生活质量。
作者 王中刚
机构地区 山东省济宁市精神病防治院精神一科
出处 《神经疾病与精神卫生》 2012年第6期621-623,共3页 Journal of Neuroscience and Mental Health
关键词 精神分裂症 认知功能 机制 治疗 Schizophrenia Cognitive impairments Mechanisms Treatments
分类号 R749.16 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献19

  • 1向云.精神分裂症与认知功能障碍[J].中国行为医学科学,2005,14(7):620-622. 被引量：65
  • 2Green MF,Nuechterlein KH,Kern RS. Functional coprimary measures for clinical trials in schizophrenia:results from the MATRICS Psychometric and Standardization Study[J].American Journal of Psychiatry,2008,(02):221-228.
  • 3Gray JA,Roth BL. Molecular targets for treating cognitive dysfunction in schizophrenia[J].Schizophrenia Bulletin,2007,(05):1100-1119.doi:10.1093/schbul/sbm074.
  • 4Davis K,Kahn R,Ko G. Dopamine in schizophrenia:a review and reconceptualization[J].American Journal of Psychiatry,1991,(11):1474-1486.
  • 5Granon S,Passetti F,Thomas KL. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex[J].The Journal of Neuroscience,2000,(03):1208-1215.
  • 6Okubo Y,Suhara T,Suzuki K. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET[J].Nature,1997,(6617):634-636.doi:10.1038/385634a0.
  • 7Arnsten AF,Cai JX,Murphy BL. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys[J].Psychopharmacology(Berlin),1994,(02):143-151.
  • 8Tarazi FI,Zhang K,Baldessarini RJ. Dopamine D4 receptors:beyond schizophrenia[J].Journal of Receptor and Signal Transduction Research,2004,(03):131-147.
  • 9Stenberg JH,Terevnikov V,Joffe M. Effects of add-on mirtazapine on neurocognition in schizophrenia:a doubleblind,randomized,placebo-controlled study[J].International Journal of Neuropsychopharmacology,2010,(04):433-441.
  • 10Cho SJ,Yook K,Kim B. Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone:a randomized controlled trial[J].Progress in Neuro-Psychopharmacology & Biological Psychiatry,2011,(01):208-211.

二级参考文献15

  • 1Elliott R. Executive functions and their disorders.Imaging neuroscience: Clinical frontiers for diagnosis and management.Br Med Bull,2003,65:49-59.
  • 2Carlsson A, Hansson LO. A glutaergic deficiency model of schizophrenia. Br J Psychiatry, 1999,174(Suppl 37):2.
  • 3Wassef A,Baker J, Kochan LD. GABA and Schizophrenia: A review of basic science and clinical studies. J Clin Psychopharmacology, 2003,23(6):601-640.
  • 4Stip E,Remington GJ, Dursun S, et al. A Canadian Multicenter Trial Assessing Memory and Executive Functions in Patients With Schizophrenia Spectrum Disorders Treated With Olanzapine.J Clin Psychopharmacology, 2003,23(4):400-404.
  • 5Goldberg TE, Torrey EF, Davidso R, et al. Risk of neuropsychological impairment in monozygotic twins discordant and concordant for schizophrenia. Schizophr Res,1995,17:77-84.
  • 6Medalia A, Lim R. Treatment of Cognitive Dysfunction in Psychiatric Disorders. Journal of Psychiatric Practice,2004,10(1):17-25.
  • 7Hoff AL,Kremen WS. Is there a cognitive phenotype for schizophrenia: the nature and course of the disturbance in cognition? Current Opinion in Psychiatry, 2002,15(1):43-48.
  • 8Tollefson GD. Cognitive function in schizophrenic patients. J Clin Psychiatry, 1996,57(Suppl):31-39.
  • 9Hoff AL, Kremen WS. Neuropsychology in schizophrenia: an update. Current Opinion in Psychiatry, 2003,16(2):149-155.
  • 10赵靖平,杨德森.精神分裂症认知功能的研究进展[J].中华精神科杂志,1998,31(1):58-59. 被引量：195

共引文献64

同被引文献34

引证文献3

二级引证文献14

神经疾病与精神卫生
2012年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部